halofenate has been researched along with troglitazone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
Beaumont, KA; Boyle, GM; Cook, AL; Muscat, GE; Parsons, PG; Smit, DJ; Smith, AG; Sturm, RA; Thurber, AE | 1 |
2 other study(ies) available for halofenate and troglitazone
Article | Year |
---|---|
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |
PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells.
Topics: Animals; Antineoplastic Agents; beta Catenin; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Chlorocebus aethiops; Chromans; COS Cells; Halofenate; Humans; Melanoma; PPAR gamma; RNA, Messenger; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Troglitazone; Wnt Proteins | 2009 |